ARCHIVES

CCOP Controversy Goes On: DCT Board Objects, Says It Was Left Out; Moorhead, DeVita Clarify Positions

This article is from The Cancer Letter archive.

Vol. 08 No. 08 | February 19, 1982

Download PDF Visit The Full Archive

Related Articles

Symposium to Focus on New Approaches to Drug Resistance

May 11, 1990

NCI Encourages IP Chemo For Stage III Ovarian Cancer

January 27, 2006

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

Chabner Criticizes FDA Crackdown On Off-Label Info

June 28, 1991

In Brief: Commerce Dept. Open Radiation Standards Facility For Mammography Calibration

April 4, 1996

Committee, BSC Recommend Against Continuing Women’s Health Trial; Appeal to NCAB Seen

January 15, 1988